Trials / Withdrawn
WithdrawnNCT04292392
Pain Levels and Opioid Usage in Three Nerve Block Cohorts in Primary TKA
Comparison of Pain Levels and Opioid Usage in ACB + Periarticular Block vs. ACB + IPACK Block vs. ACB + IPACK + Periarticular Block in Patients Undergoing Primary TKA
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- University of Louisville · Academic / Other
- Sex
- All
- Age
- 22 Years – 89 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study is to compare effect of combined block of ACB (adductor canal block) with IPACK (Interspace between the Popliteal Artery and the Capsule of the posterior Knee) block and/or Intra-articular block in immediate postoperative and early postop rehabilitation and pain management in patients undergoing primary TKA. The secondary objective is to review both in-hospital and post-discharge pain levels and narcotic usage of primary TKAs, with a minimum 6-week postoperative follow-up.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | preop ACB, followed by Intra-articular block during TKA surgery | Preoperative ACB (adductor canal block), followed by a local anesthetic injection during surgery, which is comprised of the following agents and amounts: * Ropivacaine 5mg/ml (49.25ml) * Epinephrine 1mg/ml (0.5ml) * Ketorolac 30mg/ml (1ml) * Clonidine 0.1mg/ml (0.8ml) * Saline 48.45ml |
| OTHER | preop ACB+IPACK block | Preoperative ACB (adductor canal block) and IPACK (Interspace between the Popliteal Artery and the Capsule of the posterior Knee) block |
| OTHER | preop ACB+IPACK block, followed by Intra-articular block during TKA surgery | Preoperative ACB (adductor canal block) and IPACK (Interspace between the Popliteal Artery and the Capsule of the posterior Knee) block, followed by a local anesthetic injection during surgery, which is comprised of the following agents and amounts: * Ropivacaine 5mg/ml (49.25ml) * Epinephrine 1mg/ml (0.5ml) * Ketorolac 30mg/ml (1ml) * Clonidine 0.1mg/ml (0.8ml) * Saline 48.45ml |
Timeline
- Start date
- 2020-04-06
- Primary completion
- 2020-08-15
- Completion
- 2020-09-30
- First posted
- 2020-03-03
- Last updated
- 2020-11-04
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04292392. Inclusion in this directory is not an endorsement.